Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP552021.RASS4T6VhFS2Dlg82HDpuYQQXzaDOWvcN0tHi_Lg8Q_SE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP552021.RASS4T6VhFS2Dlg82HDpuYQQXzaDOWvcN0tHi_Lg8Q_SE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP552021.RASS4T6VhFS2Dlg82HDpuYQQXzaDOWvcN0tHi_Lg8Q_SE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP552021.RASS4T6VhFS2Dlg82HDpuYQQXzaDOWvcN0tHi_Lg8Q_SE130_provenance.
- befree-2016 importedOn "2016-02-19" NP552021.RASS4T6VhFS2Dlg82HDpuYQQXzaDOWvcN0tHi_Lg8Q_SE130_provenance.
- NP552021.RASS4T6VhFS2Dlg82HDpuYQQXzaDOWvcN0tHi_Lg8Q_SE130_assertion wasGeneratedBy ECO_0000203 NP552021.RASS4T6VhFS2Dlg82HDpuYQQXzaDOWvcN0tHi_Lg8Q_SE130_provenance.
- NP552021.RASS4T6VhFS2Dlg82HDpuYQQXzaDOWvcN0tHi_Lg8Q_SE130_assertion wasDerivedFrom befree-2016 NP552021.RASS4T6VhFS2Dlg82HDpuYQQXzaDOWvcN0tHi_Lg8Q_SE130_provenance.
- NP552021.RASS4T6VhFS2Dlg82HDpuYQQXzaDOWvcN0tHi_Lg8Q_SE130_assertion SIO_000772 16733374 NP552021.RASS4T6VhFS2Dlg82HDpuYQQXzaDOWvcN0tHi_Lg8Q_SE130_provenance.
- NP552021.RASS4T6VhFS2Dlg82HDpuYQQXzaDOWvcN0tHi_Lg8Q_SE130_assertion evidence source_evidence_literature NP552021.RASS4T6VhFS2Dlg82HDpuYQQXzaDOWvcN0tHi_Lg8Q_SE130_provenance.
- NP552021.RASS4T6VhFS2Dlg82HDpuYQQXzaDOWvcN0tHi_Lg8Q_SE130_assertion description "[To evaluate in naive patients with chronic hepatitis C 1- the efficacy and safety of one month interferon alpha (IFN-alpha) induction regimen; 2- the potential virological benefit of a secondary adjunction of ribavirin among HCV RNA negative patients after 20 weeks of IFN therapy, with or without an initial 4-week IFN induction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP552021.RASS4T6VhFS2Dlg82HDpuYQQXzaDOWvcN0tHi_Lg8Q_SE130_provenance.